Literature DB >> 24241034

α9β1 integrin acts as a critical intrinsic regulator of human rheumatoid arthritis.

Tsuyoshi Asano1, Norimasa Iwasaki, Shigeyuki Kon, Masashi Kanayama, Junko Morimoto, Akio Minami, Toshimitsu Uede.   

Abstract

OBJECTIVE: The role of the joint tissue microenvironment in the pathogenesis of human RA has recently attracted much attention. The present study investigated the roles of α9β1 integrin and its ligands in synovial specimens of human RA patients in generating the unique human arthritic tissue microenvironment.
METHODS: Synovial fibroblasts and macrophages were isolated from the synovial tissue of patients with RA or OA. The expression of α9β1 integrin was analysed using FACS with multicolour staining. The production of MMPs and proinflammatory cytokines was analysed in cultures of synovial fibroblasts and macrophages with α9β1 integrin ligands.
RESULTS: Synovial fibroblasts and macrophages derived from arthritic joints spontaneously secreted tenascin-C and osteopontin. Synovial fibroblasts and macrophages obtained from patients with RA expressed α9β1 integrins, a common receptor for osteopontin and tenascin-C. In the synovial fibroblasts of RA, the amount of tenascin-C protein produced was much greater than that of osteopontin in synovial fibroblasts of RA. Importantly, autocrine and paracrine interactions of α9β1 integrin and tenascin-C induced the expression of MMPs and IL-6 in synovial fibroblasts, as well as TNF-α and IL-1β in synovial macrophages.
CONCLUSION: These findings indicate that autocrine and paracrine interaction of α9β1 integrin and tenascin-C in the joint tissue microenvironment contributes to the pathogenesis of RA. Therefore α9β1 integrin may become a potential therapeutic target for RA.

Entities:  

Keywords:  integrin; osteopontin; rheumatoid arthritis; synovial fibroblast; tenascin-C

Mesh:

Substances:

Year:  2013        PMID: 24241034     DOI: 10.1093/rheumatology/ket371

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

Review 1.  Role of integrins and their ligands in osteoarthritic cartilage.

Authors:  Jian Tian; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2014-09-27       Impact factor: 2.631

2.  The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Authors:  Shigeyuki Kon; Toshimitsu Uede
Journal:  J Cell Commun Signal       Date:  2017-10-03       Impact factor: 5.782

3.  Constitutive Activation of Integrin α9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis.

Authors:  Takashi Emori; Jun Hirose; Kotoko Ise; Jun-Ichiro Yomoda; Michiko Kasahara; Tadanobu Shinkuma; Hiroyuki Yoshitomi; Hiromu Ito; Motomu Hashimoto; Shingo Sugahara; Hirotada Fujita; Nobuchika Yamamoto; Yoshiaki Morita; Shuh Narumiya; Ichiro Aramori
Journal:  J Immunol       Date:  2017-10-16       Impact factor: 5.422

Review 4.  Role of osteopontin in rheumatoid arthritis.

Authors:  Fangjie Zhang; Wei Luo; Yusheng Li; Shuguang Gao; Guanghua Lei
Journal:  Rheumatol Int       Date:  2014-08-28       Impact factor: 2.631

Review 5.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

6.  Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

Authors:  Jingchao Hao; Xiaodong Wu; Sarra Setrerrahmane; Kun Qian; Yueying Hou; Liting Yu; Chenyu Lin; Qianqian Wu; Hanmei Xu
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

Review 7.  Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights.

Authors:  Shihan Xu; Tingwei Zhang; Zhengguo Cao; Wenjie Zhong; Chuangwei Zhang; Han Li; Jinlin Song
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

8.  Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.

Authors:  Takuro Kobori; Shinichi Hamasaki; Atsuhiro Kitaura; Yui Yamazaki; Takashi Nishinaka; Atsuko Niwa; Shinichi Nakao; Hidenori Wake; Shuji Mori; Tadashi Yoshino; Masahiro Nishibori; Hideo Takahashi
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

9.  ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial.

Authors:  Tsutomu Takeuchi; Yoshiya Tanaka; Jay Erdman; Yuichiro Kaneko; Masako Saito; Chieri Higashitani; Ronald Smulders; Christopher Lademacher
Journal:  Arthritis Res Ther       Date:  2020-10-21       Impact factor: 5.156

Review 10.  Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.

Authors:  Masahiro Hasegawa; Toshimichi Yoshida; Akihiro Sudo
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.